| scholarly article | Q13442814 |
| P2093 | author name string | Jiewen Zhang | |
| Yanjie Jia | |||
| Yanru Liu | |||
| Boai Zhang | |||
| Zhikun Sun | |||
| Xingrong Ma | |||
| P2860 | cites work | Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms | Q24648759 |
| Curcuminoids and resveratrol as anti-Alzheimer agents | Q26829183 | ||
| SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis | Q28583941 | ||
| Therapeutic potential of resveratrol in Alzheimer's disease | Q30855117 | ||
| Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment | Q33552656 | ||
| White Matter Damage and Hippocampal Neurodegeneration Induced by Permanent Bilateral Occlusion of Common Carotid Artery in the Rat: Comparison between Wistar and Sprague-Dawley Strain | Q33633987 | ||
| Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease | Q33944063 | ||
| Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions. | Q34127988 | ||
| Neuroprotective and metabolic effects of resveratrol: therapeutic implications for Huntington's disease and other neurodegenerative disorders | Q34215149 | ||
| Long lasting local and systemic inflammation after cerebral hypoxic ischemia in newborn mice | Q34261803 | ||
| ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease | Q34424253 | ||
| Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. | Q34450913 | ||
| Isoflurane exposure during mid-adulthood attenuates age-related spatial memory impairment in APP/PS1 transgenic mice | Q34491135 | ||
| Resveratrol protects against neurotoxicity induced by kainic acid | Q34554364 | ||
| Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). | Q34615871 | ||
| Protecting against vascular disease in brain | Q34979773 | ||
| Vascular dementia may be the most common form of dementia in the elderly | Q34989449 | ||
| Progressive cognitive impairment following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries in rats. | Q52215049 | ||
| Prevalence and outcomes of vascular cognitive impairment | Q60712647 | ||
| Resveratrol causes antiatherogenic effects in an animal model of atherosclerosis | Q83200946 | ||
| Resveratrol causes antiatherogenic effects in an animal model of atherosclerosis | Q84795107 | ||
| Vascular cognitive impairment: disease mechanisms and therapeutic implications | Q35197111 | ||
| Modulation of oxidant and antioxidant enzyme expression and function in vascular cells | Q35874787 | ||
| Reactive oxygen species: influence on cerebral vascular tone | Q36371878 | ||
| The enigma of vascular cognitive disorder and vascular dementia | Q36730292 | ||
| Resveratrol for primary prevention of atherosclerosis: clinical trial evidence for improved gene expression in vascular endothelium. | Q36823957 | ||
| Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications | Q36979669 | ||
| Vascular dementia: prevention and treatment | Q37018866 | ||
| Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology. | Q37394526 | ||
| Determination of glutathione and glutathione disulfide in biological samples: an in-depth review | Q37533785 | ||
| Antioxidant and anti-inflammatory effects of resveratrol in airway disease. | Q37705393 | ||
| Resveratrol: a cardioprotective substance | Q37831926 | ||
| Neuroprotective properties of resveratrol and derivatives | Q37831938 | ||
| Oxidative stress in schizophrenia - focusing on the main markers. | Q37941344 | ||
| Resveratrol, a neuroprotective supplement for Alzheimer's disease. | Q37972652 | ||
| Oxidative stress and redox regulation on in vitro development of mammalian embryos | Q37997270 | ||
| Resveratrol role in cardiovascular and metabolic health and potential mechanisms of action | Q38053707 | ||
| Resveratrol-mediated downregulation of Rictor attenuates autophagic process and suppresses UV-induced skin carcinogenesis | Q39407091 | ||
| Antiproliferative effect of resveratrol in pancreatic cancer cells | Q39638532 | ||
| The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide. | Q39832644 | ||
| Inhibiting islet amyloid polypeptide fibril formation by the red wine compound resveratrol. | Q39891575 | ||
| Effects of leukemia inhibitory factor and basic fibroblast growth factor on free radicals and endogenous stem cell proliferation in a mouse model of cerebral infarction | Q42010368 | ||
| Resveratrol attenuates brain damage in a rat model of focal cerebral ischemia via up-regulation of hippocampal Bcl-2. | Q42503284 | ||
| Cerebroprotective potential of resveratrol through anti-oxidant and anti-inflammatory mechanisms in rats | Q42713131 | ||
| Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins | Q42723035 | ||
| Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease | Q43012511 | ||
| Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics | Q43012550 | ||
| Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease. | Q43157594 | ||
| Protective effect of trans-resveratrol against kainic acid-induced seizures and oxidative stress in rats | Q43867267 | ||
| Cardioprotective effect of resveratrol on lipopolysaccharide-induced oxidative stress in rat. | Q43941166 | ||
| Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity | Q44392622 | ||
| Protective effects of resveratrol and quercetin against MPP+ -induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons. | Q45998297 | ||
| Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats | Q46121091 | ||
| Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats | Q46305835 | ||
| Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease | Q46463069 | ||
| Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging | Q46491593 | ||
| Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3β and CREB through PI3-K/Akt pathways | Q47361860 | ||
| Resveratrol prevents global cerebral ischemia-induced decrease in lipid content. | Q48211817 | ||
| Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats | Q48352370 | ||
| Down-regulation of IGF-1/IGF-1R in hippocampus of rats with vascular dementia | Q48656033 | ||
| The central histamine level in rat model of vascular dementia | Q48743752 | ||
| "Effect of resveratrol on oxidative and inflammatory stress in liver and spleen of streptozotocin-induced type 1 diabetic rats". | Q50507059 | ||
| The modified 2VO ischemia protocol causes cognitive impairment similar to that induced by the standard method, but with a better survival rate | Q51030257 | ||
| High urinary levels of resveratrol metabolites are associated with a reduction in the prevalence of cardiovascular risk factors in high-risk patients. | Q51358788 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2050-2059 | |
| P577 | publication date | 2013-08-01 | |
| P1433 | published in | Neural Regeneration Research | Q15710164 |
| P1476 | title | Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia | |
| P478 | volume | 8 |
| Q59789573 | Beneficial Effects of Resveratrol Administration-Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions |
| Q55021760 | Biological Activities of Stilbenoids. |
| Q47160388 | Chronic cerebral hypoperfusion and plasticity of the posterior cerebral artery following permanent bilateral common carotid artery occlusion. |
| Q48412067 | Effects of fisetin on hyperhomocysteinemia-induced experimental endothelial dysfunction and vascular dementia. |
| Q38372396 | Effects of resveratrol on apoptosis in a rat model of vascular dementia |
| Q64084287 | Hop-Derived Iso-α-Acids in Beer Improve Visual Discrimination and Reversal Learning in Mice as Assessed by a Touch Panel Operant System |
| Q91646668 | Hypoxia-Induced Degenerative Protein Modifications Associated with Aging and Age-Associated Disorders |
| Q58603452 | Matured Hop-Derived Bitter Components in Beer Improve Hippocampus-Dependent Memory Through Activation of the Vagus Nerve |
| Q36244982 | Models and mechanisms of vascular dementia |
| Q64880531 | Natural Compounds for Alzheimer's Disease Therapy: A Systematic Review of Preclinical and Clinical Studies. |
| Q26750581 | Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview |
| Q89619566 | Neuroprotective Effect of Resveratrol via Activation of Sirt1 Signaling in a Rat Model of Combined Diabetes and Alzheimer's Disease |
| Q48400442 | Prevention of hypertension-induced vascular dementia by Lactobacillus paracasei subsp. paracasei NTU 101-fermented products |
| Q42320739 | Resveratrol Increases Serum BDNF Concentrations and Reduces Vascular Smooth Muscle Cells Contractility via a NOS-3-Independent Mechanism |
| Q92060620 | Resveratrol Prevents Cognitive Impairment in Type 2 Diabetic Mice by Upregulating Nrf2 Expression and Transcriptional Level |
| Q92276957 | Resveratrol and cognitive decline: a clinician perspective |
| Q33784931 | Resveratrol protects against ICV collagenase-induced neurobehavioral and biochemical deficits |
| Q93271304 | Resveratrol-Inspired Bridged Bicyclic Compounds: A New Compound Class for the Protection of Synaptic Function from Acute Oxidative Stress |
| Q64056018 | Roles for osteocalcin in brain signalling: implications in cognition- and motor-related disorders |
| Q89658090 | Small Vessel Disease-Related Dementia: An Invalid Neurovascular Coupling? |
| Q26795415 | The Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer's Disease and Vascular Dementia |
Search more.